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SUMMARY
Dysregulated mitophagy has been linked to Parkin-
son’s disease (PD) due to the role of PTEN-induced
kinase 1 (PINK1) inmediating depolarization-induced
mitophagy in vitro. Elegant mouse reporters have
revealed the pervasive nature of basal mitophagy
in vivo, yet the role of PINK1 and tissue metabolic
context remains unknown. Usingmito-QC, we inves-
tigated the contribution of PINK1 to mitophagy in
metabolically active tissues. We observed a high
degree of mitophagy in neural cells, including PD-
relevant mesencephalic dopaminergic neurons and
microglia. In all tissues apart from pancreatic islets,
loss of Pink1 did not influence basal mitophagy,
despite disrupting depolarization-induced Parkin
activation. Our findings provide the first in vivo evi-
dence that PINK1 is detectable at basal levels and
that basal mammalian mitophagy occurs indepen-
dently of PINK1. This suggests multiple, yet-to-
be-discovered pathways orchestrating mammalian
mitochondrial integrity in a context-dependent
fashion, and this has profound implications for our
molecular understanding of vertebrate mitophagy.
INTRODUCTION
Recently, research has elaborated the mechanisms by which
two enzymes, PTEN-induced kinase 1 (PINK1) and Parkin,
mediate a mitochondrial quality control pathway, which leads
to removal of damaged mitochondria by selective autophagy
(mitophagy; McWilliams and Muqit, 2017). Mitochondrial dam-
age activates themitochondrial-associated kinase PINK1, which
in turn phosphorylates both ubiquitin and the cytosolic E3-ubiq-
uitin ligase Parkin at their respective Ser65 residues. This initi-
ates a feedforward amplification cascade of mitochondrial
ubiquitylation that drives clearance of the damaged organelle
via mitophagy (Ordureau et al., 2014). As mutations in human
PINK1 (PARK6) and Parkin (PARK2) are causative for early-onset
Parkinson’s disease (PD), aberrant mitophagy has emerged as
an attractive hypothesis to explain the pathophysiology of this
neurodegenerative movement disorder (McWilliams and Muqit,
2017; Whitworth and Pallanck, 2017). Although PINK1 is re-
garded as a master regulator of mitophagy, little is known about
its exact contribution to mammalian mitophagy in vivo. This
paucity of data is largely due to the difficulty of studying both
endogenous PINK1 signaling and mitophagy in mammalian tis-
sues. Furthermore, the majority of studies on PINK1-dependent
mitophagy have been conducted using overexpressed proteins
and mitochondrial uncoupling agents that artificially induce de-
polarization in cultured cells, creating a conspicuous asymmetry
between observations of PINK1-mediated mitochondrial clear-
ance in vitro and its relevance to the regulation of mitophagy
in vivo. We recently demonstrated the striking nature of basal
mitophagy in vivo using the mito-QC mouse model, a fluores-
cence-based reporter, which enables the subcellular visualiza-
tion of mitochondrial architecture and mitophagy in tissues
(McWilliams andGanley, 2016; McWilliams et al., 2016). To inter-
rogate the function of PINK1 in regulating basal mitophagy
in vivo, we characterized Pink1 wild-type (WT) and knockout
(KO) mice expressing the mito-QC transgene, focusing on tis-
sues of high metabolic dependence and cell types of clinical
importance to PD. We report basal mitophagy in subsets of
highly metabolic cells in vivo, including dopaminergic (DA) neu-
rons, retinal photoreceptor neurons, and exocrine pancreatic
acinar cells. Furthermore, across a range of quantitative param-
eters, we demonstrate that basal mitophagy in vivo occurs inde-
pendently of PINK1 in a variety of tissues. Our findings are further
substantiated by the biochemical detection and validation of
endogenous PINK1 within tissues. These findings broaden our
understanding of mitochondrial homeostasis in vivo, suggesting
undiscovered regulators and mechanisms.
RESULTS
mito-QC Reports Endogenous PINK1-Dependent and
Independent Stress-Evoked Mitophagy
We previously validated mito-QC as a bona-fide endpoint
mitophagy reporter in cultured cells and tissues (Allen et al.,
2013; McWilliams et al., 2016). To assess the contribution of
mammalian PINK1 to basal mitophagy in vivo, we crossed
Pink1 KO and mito-QC reporter mice to obtain Pink1 WT
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Figure 1. Detection of PINK1-Dependent Mitophagy In Vitro and Detection of Endogenous PINK1 Protein at Basal Levels In Vivo
(A) Primary MEF cultures established from Pink1+/+ mito-QC+/+ and Pink1/ mito-QC+/+ littermate embryos were transduced with retroviral HA-Parkin, and
stimulated with DMSO (Control), CCCP, or DFP for 24 hr. Mitophagy (mCherry-only mitolysosomes) was visualized by confocal microscopy.
(B) Mitophagy was readily observed in CCCP-treated WT and not in KO MEFs (two-way ANOVA, Bonferroni correction: ***p < 0.001, **p < 0.01; n.s., p > 0.05).
(C) Immunoblot showing levels of exogenous HA-Parkin and endogenous PINK1 protein following CCCP treatment in Pink1 WT and KO mito-QC MEFs.
Diminished levels of the Parkin substrate CISD1 and equal loading using vinculin are shown.
(D) Pancreas sections from mCherry-GFP-LC3 mice and mito-QC animals from fasting experiments.
(E) Elevated levels of general autophagy are observed following a 24-hr fasting period, compared with animals fed ad libitum (Student’s t test; **p < 0.01).
A corresponding induction of mitophagy is not observed upon starvation (n.s., p > 0.05).
(legend continued on next page)
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(Pink1+/+) and KO (Pink1/) mice on a homozygous mito-QC
background. Resultant offspring were born at normal Mendelian
frequencies and exhibited no obvious physical or anatomical
abnormalities. To verify that our system faithfully detects
PINK1-dependent mitophagy, we established primary mouse
embryonic fibroblast (MEF) cultures from heterozygote matings
of Pink1+/ mito-QC+/+ animals. We transduced the resulting
Pink1 WT and KO littermate cultures with retroviral HA-Parkin,
and treated MEFs with the mitochondrial uncoupler carbonyl
cyanide 3-chlorophenylhydrazone (CCCP). Consistent with pub-
lished observations (Narendra et al., 2008), mito-QC revealed
the characteristic elimination of depolarized mitochondria in
Pink1 WT, but not Pink1 KO MEF cultures (Figures 1A and 1B).
This was associated with clear stabilization of PINK1 in CCCP-
treated WT cells only, as determined by immunoprecipitation
(IP) and immunoblot analysis of endogenous PINK1 (Figure 1C).
In parallel, we observed loss of Parkin expression (due to autou-
biquitylation upon activation) inWT, but not in KOmito-QCMEFs
treated with CCCP (Figure 1C). We previously demonstrated
that iron-chelation-induced mitophagy occurs independently of
PINK1/Parkin (Allen et al., 2013). Consistent with this, mito-QC
demonstrated deferiprone-induced mitophagy in both PINK1
WT and KO MEF cultures (Figures S1A and S1B). Our experi-
ments further confirmed that endogenous PINK1 activates HA-
Parkin E3 activity, as demonstrated by diminished levels of its
OMM substrate CISD1 in Pink1 WT, but not KO mito-QC MEFs
(Figure 1C). In cultures of primary mouse adult fibroblasts
(non-mito-QC) treated with CCCP, we also observed ubiquityla-
tion of CISD1 by endogenous Parkin and generation of phospho-
ubiquitin in Pink1 WT, but not KO samples (Figure S1C). Taken
together, our data demonstrate that mito-QC reliably reports
both PINK1-dependent and independent forms of stress-evoked
mitophagy.
To provide additional verification that mito-QC monitors the
selective autophagy of mitochondria in vivo, we generated
another fluorescence-based reporter mouse to visualize general
macroautophagy based on the same principle. This model was
generated by knock in of mCherry-GFP-LC3 (mCherry-GFP-
Map1lc3b) at theRosa26 locus, as formito-QC (Figure S1D). Un-
der normal conditions, the reporter displays a diffuse cytosolic
staining pattern, but is recruited to autophagosomes during
autophagy, which appear both green and red. Upon autophago-
some-lysosome fusion, GFP fluorescence is quenched and
mCherry-only puncta serve as markers of resultant autolyso-
somes. Using both mitophagy and autophagy reporter mouse
models, we performed the classical starvation experiment previ-
ously described by the Mizushima laboratory (Mizushima et al.,
2004). After a 24-hr fasting period, we observed elevated macro-
autophagy in the pancreas as described previously (Figures 1D
and 1E). Notably, we did not detect differences in mitophagy
between fasted and non-fasted animals (pancreatic mitophagy
is detailed in Figure 4 and discussed thereafter). These data
show that under identical starvation conditions, mito-QC selec-
tively reports mitophagy, demonstrating the specificity of the re-
porter as well as highlighting the differing requirements that
regulate mitophagy versus starvation-induced autophagy.
In cell culture, under normal conditions, PINK1 is undetectable
due to rapid turnover via constitutive N-end rule degradation (Ya-
mano and Youle, 2013). As PINK1 only becomes stabilized and
activated upon mitochondrial depolarization, it has been widely
assumed that PINK1 would not be detectable at basal levels in
normal, healthy tissue. This view is further entrenched by a
lack of tools that facilitate the robust detection of mouse
PINK1 at basal levels in vivo, which can also be verified by essen-
tial KO controls. Our biochemical MEF data demonstrate that we
can detect endogenous PINK1 using two in-house generated
antibodies (Figure 1C). Thus, we investigated if PINK1 is detect-
able at basal levels within tissues, notably in the CNS. We per-
formed IPs from total brain extracts from Pink1 WT and KO
mice. We were able to clearly detect a 60-kDa band correspond-
ing to mouse PINK1 in WT brain lysates, which was absent in the
KO samples (Figure 1F). We employed mass spectrometry (MS)
to obtain gold-standard analytical verification of our biochemical
results (Figures 1G and S1E). Satisfyingly, MS analysis revealed
peptides corresponding to PINK1 in samples from WT but not
KO mice (Figures 1G and S1E). Our rigorous approach provides
conclusive evidence that PINK1 protein is present in the mouse
brain under normal physiological conditions.
Pink1 Is Dispensable for Basal Neural Mitophagy In Vivo
Wenext sought to obtain a spatial snapshot of PINK1 expression
in themammalian nervous system. Todo this, wemicrodissected
neural substructures from Pink1WT and KO adult mouse brains,
obtained protein lysates, and used our validated biochemical
IP approach to detect PINK1. We observed PINK1 expression
across all CNS regions,with particular enrichment in the striatum,
neocortex, cerebellum, and spinal cord. Interestingly, we de-
tected lower levels of PINK1 in the olfactory bulbs (Figure 2D).
This suggests that PINK1 may undergo differential processing
at different rates within distinct regions of the adult brain.
Neural tissue has a very high energy demand, and mainte-
nance of mitochondrial homeostasis is essential to sustain this.
Aberrant mitochondrial quality control is predicted to underlie
several neurodegenerative disorders, including PD, which is
characterized by the progressive loss of A9 DA nigrostriatal pro-
jection fibers (Grealish et al., 2010; Poewe et al., 2017). Although
impaired mitophagy has been proposed as a main contributor
to DA neurodegeneration, evidence as to whether DA neurons
undergo basal mitophagy in vivo, and to what degree, has re-
mained elusive. We thus performed comparative analyses of mi-
tophagy in brain sections from Pink1WT and KOmito-QC mice,
where total brain extracts showed that themito-QC reporter was
similarly expressed in both Pink1 WT and KO animals, and that
mitochondrial protein expression was comparable (Figure S2A).
(F) IP-immunoblot showing biochemical detection of endogenous PINK1 protein in mouse brain homogenates, n = 2 animals per genotype. PINK1 protein is
detectable at basal levels using enrichment by IP, but not in whole-cell lysates (inputs). Note the absence of the PINK1 band in the immunoglobulin G (IgG) control
and KO samples.
(G) Analytical validation of PINK1 biochemical experiments by mass spectrometry. Example of extracted-ion chromatograms detailing two unique PINK1
peptides present in IP’s from WT, but not PINK1 KO cortex and cerebellum. Data are represented as mean ± SEM.
Scale bars, 5 mm. See also Figure S1.
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Figure 2. Basal Mitophagy Proceeds in the Mammalian Dopaminergic System In Vivo in the Absence of Pink1
(A) Representative micrograph showing immunolabeled midbrain dopaminergic neurons undergoing basal mitophagy in vivo. Sections ofmito-QCmouse ventral
midbrain were labeled with antibodies to the DA marker tyrosine hydroxylase (TH) and LAMP1 (inset: arrows indicate mitolysosomes and arrowheads show
mitochondria).
(B) Collapsed Z projection of a midbrain dopaminergic neuron with corresponding isosurface render (below), detailing 3D localization of mitolysosomes.
(C) Instances of axonal mitophagy in nigrostriatal DA projections are less frequent compared with DA somata. Low-power micrograph showing region of
dorsolateral striatum revealed by TH. Panels show instances of axonal mitophagy (arrows, 1 and 2), where LAMP1-positive mitolysosomes are detected within
terminal DA axons in vivo.
(legend continued on next page)
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Midbrain DA (mesDA) neurons were distinguished using the
catecholaminergic marker, tyrosine hydroxylase (TH), to identify
cell-specific mitophagy. Given the ontogeny of nigrostriatal pro-
jections, transverse brain sections were employed to investigate
mitophagy in somata, axonal projections, and terminal arbors
of the entire pathway. This orientation also enabled a valuable
comparative assessment of mitophagy in other DA populations,
such as the adjacent A10 DA neurons of the ventral tegmental
area, and A11 DA neurons of the periventricular hypothalamus.
Intriguingly, we observed high levels of mitophagy in the somata
of TH-positive nigral DA neurons (Figures 2A, 2B, and S2B).
LAMP1-immunostaining confirmed the lysosomal origin of
morphologically distinct mitolysosomes within DA neurons (Fig-
ures 2A and 2C). The reporter signal also revealed the somata
of TH-positive DA neurons to have a low mitochondrial mass,
consistent with previously published electron microscopic
studies (Liang et al., 2007). Maximum intensity projections com-
bined with volume surface rendering of immunostained struc-
tures enabled us to visualize the spatial nature of nigrostriatal
mitophagy in 3D (Figures 2B and S2B). Although we observed
minimal turnover in DA processes, we detected several in-
stances of mitophagy enriched in, or proximal to, the axon initial
segments/hillocks of DA neurons. These findings suggest that
mitophagy within DA neurons is likely to be a dynamic process
in vivo. Although we found limited numbers of mitolysosomes
within DA terminal arbors (Figure 2C), we cannot preclude a
model of retrograde transport where mitophagosomes formed
in distal DA compartments, may fuse with lysosomes at a region
proximal to or within the somata. Alternatively, it is also plausible
that the enrichment of mitolysosomes in DA somata may arise
from the destruction of local mitochondria. This could represent
a distinct mitochondrial QC checkpoint in neurons, whereby
constitutive mitochondrial-damage surveillance in the cell body
prevents defective mitochondria from entering axons. Further
work will be needed to clarify this. Our data demonstrate a close
correlation between the high levels of DA mitophagy and the
previously reported high metabolic activity of these cell types
(Pacelli et al., 2015). In all instances, basal mitophagy was
indistinguishable between Pink1 WT and KO animals (Figures
2E and S2C).
We extended our analysis to another PD-related DA popula-
tion of clinical interest, the rostral A16 periglomerular DA neurons
(PGNs) of the olfactory bulb. Olfactory dysfunction, in particular
hyposmia, affects 90% of all PD patients and is a well-estab-
lished pre-motor symptom, although the mechanisms are not
fully understood (Doty, 2012b; Markopoulou et al., 1997; Ponsen
et al., 2004). PGNs mediate lateral inhibition of mitral neurons
within the olfactory bulb (Martinez and Freeman, 1984) and in
contrast to the selective degeneration of A9 neurons, PGNs
are known to double in number in human PD patients and in
pre-clinical neurotoxin models of PD (Huisman et al., 2004). As
with the A9 and A10 population of DA neurons, we observed
robust levels of mitophagy in PGNs, with most turnover confined
to somata (Figure S2D). Morphologically, PGNs are described as
‘‘axonless’’ ultrashort projection neurons (Doty, 2012a). Similar
to the other DA populations we assessed, both Pink1 WT
and KO PGNs exhibited comparable levels of mitophagy (Fig-
ure S2E). 3D isosurface rendering revealed the complex associ-
ations of olfactory DA neurons and mitochondrial-rich glomeruli
(Figures S2D–S2F), where olfactory receptor neurons synapse
with PGNs. Surprisingly, little mitophagy is observed in this
area, consistent with our observations that most DA neuronal
mitophagy occurs within somata. We also explored mitophagy
in diencephalic DA neurons. These DA neurons undergo a lower
degree of mitophagy than other subtypes we assessed, yet no
differences were observed between Pink1 WT and KO neurons
(data not shown). As we can detect PINK1 protein in the nervous
system and basal mitophagy in the DA neurons, our results
demonstrate that loss of PINK1 does not perturb basal neuronal
mitophagy in vivo.
Basal Mitophagy in Non-neuronal Cells Occurs
Independently of Pink1
Microglia have emerged as important mediators of develop-
ment and neuroinflammation in the vertebrate nervous system.
Furthermore, PINK1 has been reported to influence the function
of these non-neuronal cells (Flinn et al., 2013; Kim et al., 2013;
Mondelli et al., 2017; Perry and Holmes, 2014). We labeled
sections with anti-Iba1 to assess mitophagy within microglia
in vivo. We detected basal mitophagy within cortical and hippo-
campal-resident Iba1-positive microglia (Figure 3A), visualiza-
tion of which was facilitated by 3D rendering (Figure 3B).
Comparative analysis revealed no pronounced differences in
microglial mitophagy between Pink1 WT and KO mice (Figures
3C, 3D, and S3C).
A consistent observation during our studies has been the
intimate association of cerebral vasculature with neurons and
neuroglia, which was highlighted by the prominent expression
of themito-QC reporter within the vascular network. The relation-
ship between cerebral vasculature, neural activity, and meta-
bolism are well documented, and the study of cerebrovascular
mitochondria has major translational implications for several
neurological disorders (Kluge et al., 2013; Zlokovic, 2011).
Although the neurogliovascular complex is a fundamental unit of
the nervous system, it is verydifficult to study the integrativemito-
chondrial biology of such complex associations in vitro. In mito-
QC brain sections, we easily resolved individual mitochondria
in blood vessels, and consistently observed robust levels of
vascular mitophagy (Figures 3E and 3F). PINK1 has also been re-
ported to function in vasculature, yet neurovascular mitophagy
was comparable between Pink1 WT and KO mito-QC animals
(Figures 3G and S3C). We also observed evidence for mitophagy
(D) IP-immunoblot showing rostro-caudal expression pattern of PINK1 protein in the adult mouse nervous system under basal conditions. PINK1 is differentially
expressed in lysates of sub-dissected adult mouse brain. OB, olfactory bulb; CTX, neocortex; STR, striatum; Thal, thalamus; VM, ventral midbrain; HC,
hippocampus; CB, cerebellum; BST, brainstem; SPC, spinal cord. CCCP-treated MEFs and total brain homogenates from Pink1 WT and KO demonstrate the
specificity of the endogenous PINK1 band.
(E) Analyses of mitophagy in the nigrostriatal system of Pink1WT and KO animals reveal no differences between genotypes (Student’s t test; n.s., p > 0.05). Data
are represented as mean ± SEM.
Scale bars, 5 mm. See also Figure S2.
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Figure 3. Microglia and Cerebrovascular
Mitophagy Occurs Independently of Pink1
In Vivo
(A) Iba1-positive microglia exhibit robust mitochon-
drial clearance in vivo. Confocal photomicrograph
shows microglial cell undergoing mitophagy inti-
mately associated with vasculature (v). Arrows indi-
cate mitolysosomes within microglia.
(B) Isosurface rendering highlights the 3D spatial
arrangement of microglial mitochondria and mitoly-
sosomes in vivo.
(C) Representative images of microglial mitophagy
in Pink1 WT and KO mice.
(D) Quantitation of microglial mitophagy.
(E) Representative image showing basal mitophagy
in adult striatal vasculature in vivo with associated
rendered 3D projection detailing mitochondrial ar-
chitecture. Arrows indicate examples of mitolyso-
somes.
(F) Airyscan cross-section of a striatal blood vessel
details arrangement of vascular mitochondria and
mitolysosomes in vivo. L indicates lumen and V de-
notes vessel. Arrows indicate examples of mitoly-
sosomes.
(G) Quantitation of cerebrovascular mitophagy in
Pink1WTandKOmice (Student’s t test; n.s., p>0.05).
Data are represented as mean ± SEM.
Scale bars, 5 mm. See also Figure S2.
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inGFAP-positiveastrocytes in vivo (FigureS2G).Ourdataunearth
the selective degradation of mitochondria in mammalian micro-
glia and vasculature in vivo, and show that basal mitophagy pro-
ceeds in the absence of Pink1 in non-neuronal cells. These data
will be important to better understandmitochondrial QC in neuro-
inflammatory and cerebrovascular diseases.
PINK1-Independent Basal Mitophagy in Tissues of High
Metabolic Demand
As we could detect PINK1 protein at basal levels in the nervous
system, we next assayed its expression across a range of meta-
bolically active tissues (Figure 4A). PINK1 was expressed in the
brain as well as in the heart, liver, kidney, and pancreas (Fig-
ure 4A). The metabolic demands of the heart are well described,
and Pink1 has been proposed to play key functions in cardiac
mitochondrial homeostasis (Billia et al., 2011). However, a
comparative assessment ofmitophagy in Pink1WT andKO adult
heart sections revealed no differences in the number of cardiac
mitolysosomes (Figures 4B and 4C). Furthermore, assessment
of mitochondrial morphology obtained from the GFP channel, re-
vealed no differences in the animals we assessed (Figure S3C).
We next extended our analysis of mitophagy to other tissues of
high metabolic dependence. We and others have previously re-
ported high levels of hepatic mitophagy (McWilliams et al., 2016;
Menzies and Gold, 1971). Upon investigation of liver sections
from Pink1 WT and KO mice we found no overt differences in
levels of mitophagy between genotypes (data not shown).
A constituent tissue of the CNS, the retina has been suggested
to be one of the most metabolically active tissue in mammals
(Ames et al., 1992; Wong-Riley, 2010). The eye provides a
contrast, as PINK1 protein expression was noticeably lower
than in other tissues (Figure 4A). We observed a striking tissue-
specific restriction of ocularmitophagy to the retinal outer nuclear
layer (ONL), which contains the cell bodies of the rod and cone
photoreceptor cells (Figure 4E). Airyscan microscopy revealed
an elaborate mitochondrial network in the retina, with the majority
ofmitolysosomesconfined to theONL (Figure4E).Associatedstri-
ated rectusmuscleon tissuesectionsexhibitedcomparable levels
of mitophagy (Figure S3A). Aswith other tissues assessed, loss of
Pink1 did not alter basal retinal mitophagy (Figures 4D and 4E).
During the course of our investigations we observed pro-
nouncedmitophagy in pancreatic acinar cells, which are respon-
sible for enzymatic and electrolyte release into the gastro-
intestinal tract. The pancreas is an organ of major clinical
importance due to its dysfunction in inflammatory, neoplastic,
and endocrine disease (Gerasimenko and Gerasimenko, 2012).
The OMM-localization of mito-QC facilitated the visualization of
this unique mitochondrial network with ease (Figures 4F–4H).
Acinar cells contained elongated and highly tubular stereotypi-
cally shaped mitochondria (Figures 4G and 4H). Three distinct
mitochondrial subgroups have been suggested to modulate
pancreatic acinar cell function (Johnson et al., 2003; Park et al.,
2001; Petersen, 2012). These classical discoveries were made
on isolated primary acinar cells and electron microscopy studies
of pancreatic acinar cells in vivo. Using mito-QC reporter mice,
wecould resolve sub-plasmalemmal, perinuclear, andperigranu-
lar mitochondria in sections of intact pancreas (Figure S3D).
These distinct mitochondrial subpopulations are known to buffer
intracellular calcium signaling, as well as synchronizing ATP sup-
ply to metabolic demand (Gerasimenko and Gerasimenko, 2012;
Johnson et al., 2003; Petersen, 2012). Interestingly, a recent pub-
lication describes the importance of macroautophagy to pancre-
atic acinar homeostasis (Antonucci et al., 2015). Although PINK1
is expressed in human exocrine pancreas (PARK6; Human Pro-
teinAtlas), and lossofParkinhasbeen linked topancreatic tumor-
igenesis (Sun et al., 2013; Uhlen et al., 2015), we found no differ-
ences between WT and KO Pink1 mito-QC animals (Figure 4I). In
contrast to acinar cells, less mitophagy was observed in islets
(Figures 4F and 4G). However, analysis of endocrine islet cells
showed an unexpected elevation of mitophagy in Pink1 KO ani-
mals comparedwithWT (Figure 4J). It has previously been shown
that Pink1 deficiency in pancreatic b-cells results in impaired
metabolism due to mitochondrial dysfunction (Deas et al.,
2014). Our discovery of elevated mitophagy in Pink1 KO islets
are consistent with mitochondrial impairment and suggest that,
in this scenario, PINK1-independent mitophagy can be upregu-
lated. This hints that in addition to mitophagy being decreased
during certain disease states (Sun et al., 2015), elevated mitoph-
agymay also contribute tometabolic pathophysiology. Together,
our datademonstrate thatPINK1 is dispensable for basalmitoph-
agy in a variety of tissues, and the degree of mitophagy depends
on metabolic context. Future work will be essential to determine
the molecular basis of PINK1-independent mitophagy in the
pancreas, and its clinical significance in PD patients.
Figure 4. Profiling PINK1 Expression and Basal Mitophagy in Tissues of High Metabolic Demand Using Pink1 WT and KO Mice
(A) Comparative analysis of PINK1 expression in vivo. PINK1 is differentially expressed in a range of metabolically active tissues.
(B and C) Normal cardiomitophagy in Pink1 WT and KO animals in vivo.
(D) Quantitation of retinal mitophagy between genotypes. Student’s t test; n.s., p > 0.05.
(E) Mammalian retinal mitophagy in vivo. Photomicrograph of adult retina in a section of adult eye from themito-QCmouse. Individual layers are demarcated by
counterstained nuclei (Hoescht) andmito-QC expression. IPL, inner pexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer;
IS, inner segment; OS, outer segment; RPE, retinal pigmented epithelium. Shown is an Airyscan image detailing mitophagy in a region of the ONL adjacent to the
IS and representative images demonstrating that loss of Pink1 does not alter levels of basal mitophagy in the retinal ONL. Arrows indicate examples of
mitolysosomes.
(F) Mitophagy and mitochondrial networks of pancreatic acinar cells ‘‘A’’ and islets ‘‘I’’ in vivo.
(G) Airyscan microscopy details pancreatic mitophagy within exocrine acinar cells and an adjacent islet.
(H) High-resolution Airyscan image showing individual mitochondria, mitolysosomes, and nuclei of pancreatic acinar cells in vivo.
(I) Representative confocal micrographs showing pancreatic mitophagy in Pink1 WT and KO mito-QC animals. Quantitation of exocrine pancreatic mitophagy
between genotypes (Student’s t test; n.s., p > 0.05).
(J) Representative confocal micrographs of islet mitophagy in Pink1WT and KOmito-QC animals. Quantitation of endocrinemitophagy between genotypes. Data
are represented as mean ± SEM. **p < 0.01.
Scale bars, 5 mm. See also Figures S3 and S4.
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Although mito-QC can report stimulus-induced mitophagy
in vitro, we wanted to determine if the same was true in vivo.
Mitophagy has been typically studied in the context of in vitro
mitotoxicity, yet its role as a neuroprotective pathway remains
unclear. Thus, we assessed if mitophagy is induced under con-
ditions of chronic mitochondrial neurotoxicity in vivo using the
well-studied brain-penetrant mitotoxin, 3-nitroproprionic acid
(3-NPA), which irreversibly inhibits complex II of the electron
transport chain (Beal et al., 1993; Brouillet et al., 2005). Intraper-
itoneal administration of 3-NPA selectively induces striatal le-
sions in vivo, although its variability in terms of resistance and
lesion heterogeneity is well documented. Lesion studies using
3-NPA have also been shown to damage cerebral vasculature
and mitochondrial-rich peripheral organs. Using a 7-day sys-
temic administration of 3-NPA in Pink1WT and KOmito-QC an-
imals (n = 6 WT and n = 9 KO animals per 3-NPA group), we
observed a small number of heterogeneous and variable intra-
striatal lesions with elevated mitophagy; however, overall levels
of striatal mitophagy were unchanged between groups (Fig-
ure S4A). 3-NPA also induces damage to vascular endothelial
cells and increases blood-brain barrier extravasation in the stria-
tum (Duran-Vilaregut et al., 2009; Nishino et al., 1995), and the
present study describes robust levels of mitophagy in cerebro-
vasculature. We did not find any effect of 3-NPA that could
influence mitophagy in Pink1 WT and KO striatal vasculature
(Figure S4A). To determine if 3-NPA could in fact activate the
canonical PINK1-Parkin pathway, we analyzed endogenous
signaling in primary MEFs. PINK1 protein was stabilized in WT
MEFs treated with CCCP, but not 3-NPA (Figure S4B). This is
consistent with previous findings in HEK293 cells (Kondapalli
et al., 2012). 3-NPA is also known to induce peripheral pathology
in mitochondrial-rich organs such as the heart, yet cardiac mi-
tophagy was comparable between 3-NPA-treated WT and KO
animals (Figure S4A). Assessment of skeletal muscle provided
a unique opportunity to interrogate Pink1 function in mitophagy
during different metabolic contexts, as the soleus muscle is
highly oxidative, whereas the gastrocnemius is progressively
more glycolytic as distance increases from the soleus. We
observed no differences in the number of mitolysosomes be-
tweenPink1WTandKOanimals at basal levels or in those treated
with 3-NPA (data not shown). Interestingly, we observed a trend
towards elevated mitochondrial content in 3-NPA-treated Pink1
KO animals, particularly in the more oxidative muscle, signifying
an adaptive response to stress (Figures S4C and S4D). Although
the total mitochondrial signal increased, the corresponding de-
gree of mitophagy did not. Hence, when we analyzed mitophagy
as a function of increased mitochondrial content, we observed a
small, yet consistent, reduction in mitophagy in oxidative and
glycolytic muscle regions in Pink1 KO animals treated with
3-NPA (Figure S4E). Our findings indicate that, in the context of
in vivomitophagy, the function of PINK1 is cell-specific and highly
dependent upon metabolic context.
DISCUSSION
Our work reveals the in vivo prevalence of mitophagy in a variety
of organ systems and cell types of high metabolic demand. We
sought to address a longstanding question of major importance
in this field, by assessing the contribution of PINK1 to the regu-
lation of basal mitophagy in vivo. We were surprised to find that
Pink1 KO mice exhibited indistinguishable basal mitophagy
comparedwithWT animals. Apart from amodest, yet consistent,
context-dependent alteration in mitophagy levels in endocrine
pancreas and skeletal muscle, our multi-parametric analyses
did not reveal any overt differences in the number, shape, size
of mitolysosomes in tissues, or in mitochondrial morphology
across the vast majority of tissues assessed. Our demonstration
of endogenous PINK1 protein expression, at basal levels within a
range of major organ systems, strengthens our observations in
mito-QC animals. Furthermore, our approach provides a long-
awaited and rigorous framework for the biochemical detection
of mouse PINK1 protein in vivo. Coupled with the recent discov-
ery of the PINK1 X-ray crystal structure, our methods will be
important for assessing PINK1 activation using small-molecule
compounds in vivo (Kumar et al., 2017). Overall, we do not
conclude that PINK1 is dispensable for all forms of mitophagy
in vivo. Rather, we assert that distinct basal and stress-evoked
pathways exist to co-ordinate mitochondrial clearance in a
context-dependent fashion. Our data suggest that the precise
role of PINK1 in vivo remains to be defined.
Since the landmark discovery of Parkin-dependent mito-
chondrial clearance (Narendra et al., 2008), the PINK1-Parkin
pathway has quite rightly dominated the field of mitophagy
(McWilliams andMuqit, 2017; Pickrell and Youle, 2015). The clin-
ical significance of this pathway is irrefutable, yet our data show
that, in vivo, it is not the major pathway that regulates basal
mitophagy. Although our data derives from a mouse model, it
is reasonable to assume an analogous scenario in humans. PD
patients survive in the absence of a functional PINK1-dependent
mitophagy pathway, and primary locomotor symptoms do not
usually manifest until the second and third decades of life. We
speculate that a complete blockade in mitophagy would confer
a more severe phenotype.
We offer two potential explanations that may account for our
observations of PINK1-independent basal mitophagy in vivo.
(1) Mammalian cells harbor multiple mitophagy pathways that
can be triggered in response to diverse stimuli under certain con-
ditions. Therefore it is conceivable that the activation of PINK1-
dependent mitophagy is highly context-dependent in mammals,
and operates in response to a distinct type of stress. Thus, overt
differences may only become apparent between Pink1 WT and
KO mice under extreme conditions of chronic mitotoxicity or
aging. Previously, it has been shown that loss of endogenous
Parkin triggers age-dependent DA neurodegeneration under
conditions of chronic mitotoxicity in mice (Pickrell et al., 2015).
However, in this study, DA neurodegeneration resulting from
loss of endogenous Parkin in the PolgD257A background was
not ascribed to dysregulatedmitophagy, due to the already com-
plex pathological background of mutator mice (Trifunovic et al.,
2004). (2) We studied animals generated by traditional transgen-
esis, i.e., germline ablation of the Pink1 gene. Thus, develop-
mental or epistatic compensation could account for the largely
normal or unperturbed mitochondrial homeostasis observed in
Pink1 KO mito-QC animals. This was elegantly demonstrated
for Parkin in studies from the Dorn and Chan laboratories
(Gong et al., 2015; Rojansky et al., 2016). In the Dorn study,
conditional deletion of Parkin during perinatal myocardial devel-
opment caused the onset of severe cardiomyopathy (Zhang
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et al., 2008). In the Chan study, MUL1 activity was demonstrated
to operate in a parallel pathway to Parkin, potentially explaining
why Parkin KOmice do not recapitulate overt neurodegenerative
phenotypes (Rojansky et al., 2016). Accordingly, more sophisti-
cated mouse genetics may be required to observe any dramatic
effect of PINK1 on basal mitophagy in vivo. Naturally, our results
describing PINK1-independent mitophagy should provoke a re-
assessment of the precise function of PINK1 in vivo. However,
such an investigation extends beyond the scope of this current
report.
That mitophagy proceeds in the absence of PINK1 demon-
strates that very little is known about the molecular mechanisms
of basal mitophagy in vivo, and that these data should stimulate
much needed work in this area. Our data should also provoke
debate on multiple aspects of PD pathophysiology with respect
to mitophagy. Key questions still remain as to when and where
stimulus-evoked PINK1-dependent mitophagy is required
in vivo, as this may help determine much needed therapeutic
strategies for PD. Ultimately, it will be vital to identify key regula-
tors of cell and tissue-specific basal mitophagy in vivo.
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Goat anti-Rabbit IgG (H+L) Secondary Antibody,
Pacific Blue
Life Technologies (Thermo Fisher
Scientific)
Cat#: P-10994; RRID: AB_2539814
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Goat anti-Rat IgG (H+L) Cross-Adsorbed Secondary
Antibody, Alexa Fluor 633
Life Technologies (Thermo Fisher
Scientific)
Cat#: A-21094; RRID: AB_141553
(Continued on next page)
e1 Cell Metabolism 27, 439–449.e1–e5, February 6, 2018
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to, and will be fulfilled by, the Lead Contact: Ian G.
Ganley (i.ganley@dundee.ac.uk).
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
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Goat anti-Rat IgG (H+L) Secondary Antibody, HRP Life Technologies (Thermo Fisher
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Cat#: 31470; RRID: AB_228356
Rabbit anti-Sheep IgG (H+L) Secondary Antibody, HRP Life Technologies (Thermo Fisher
Scientific)
Cat#: 31480; RRID: AB_228457
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Trypsin (MS Grade) Thermo Fisher Scientific Cat#: 90058
2-Chloroacetamide Sigma-Aldrich Cat#: C-0267
Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) Sigma-Aldrich Cat#: C2759
3-Nitropropionic acid (3-NPA) Sigma-Aldrich Cat#: N5636
Deferiprone (DFP) Sigma-Aldrich Cat#: 379409
VECTASHIELD Antifade Mounting Medium Vector Laboratories Cat#: H-1000; RRID: AB_2336789
Recombinant TUBE Protein: His-Halo-UBAUBQLN1 MRC PPU Products & Reagents Cat#: DU23799
Experimental Models: Cell Lines
Human: HEK293 FT Allen et al. (2013); This Study N/A
Mouse: Primary & SV40 Immortalized Mouse
Embryonic Fibroblasts
This study N/A
Experimental Models: Organisms/Strains
Mouse model: mito-QC mice McWilliams et al. (2016); This study
(Mice generated by TaconicArtemis
GmbH)
N/A
Mouse model: Pink1 KO mice Dr. L. Miguel Martins, Leicester UK;
(Mice generated by Lexicon
Pharmaceuticals, Inc.)
N/A
Mouse model: mCherry-GFP-Map1lc3b This study (Mice generated by
TaconicArtemis GmbH)
N/A
Recombinant DNA
Plasmid: pQCXIP puro HA-Parkin MRC PPU Products & Reagents DU55566
GP2-293 Packaging Cell Line Clontech Cat#: 631458
pVSV-G Vector Clontech Cat#: 631457
Plasmid: pBabe Hygro SV40 DU40188 MRC PPU Products & Reagents DU40188
Software and Algorithms
Volocity PerkinElmer http://cellularimaging.perkinelmer.
com/downloads/
Imaris Bitplane http://www.bitplane.com/imaris
Xcalibur v2.2TM Thermo Scientific https://www.thermofisher.com/order/
catalog/product/OPTON-30487
Mascot 2.4.1 Matrix Science http://www.matrixscience.com/
Other
Zeiss LSM 710 Confocal Laser Scanning Microscope Zeiss N/A
Zeiss LSM 880 Confocal Laser Scanning
Microscope with Airyscan
Zeiss N/A
Thermo LTQ-Orbitrap Velos Thermo Fisher Scientific N/A
Thermo U3000 RSLC nano liquid chromatography system Thermo Fisher Scientific N/A
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Themito-QCmousemodel used in this studywas generated as previously described (McWilliams et al., 2016) and crossedwithPink1
heterozygote animals to produce WT and KO animals with endogenousmito-QC reporter. Autophagy reporter mice (mCherry-GFP-
Map1lc3b, referred to as mCherry-GFP-LC3) were generated using targeted transgenesis by TaconicArtemis GmbH. Recombina-
tion-mediated cassette exchange (RMCE) was used to insert a CAG promoter cassette and the open reading frame for the
mCherry-GFP-LC3 fusion protein including a Kozak sequence (GCCACC) into the mouse Rosa26 locus (protein sequence of the
mCherry-GFP-Map1lc3b fusion protein: MVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGEGEGRPYEGTQTAKLKVTKGGPLP
FAWDILSPQFMYGSKAYVKHPADIPDYLKLSFPEGFKWERVMNFEDGGVVTVTQDSSLQDGEFIYKVKLRGTNFPSDGPVMQKKTMGW
EASSERMYPEDGALKGEIKQRLKLKDGGHYDAEVKTTYKAKKPVQLPGAYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDELYKG
GGSMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFK
SAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSV
QLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEFVTAAGITLGMDELYKSGLGSMPSEKTFKQRRSFEQRVEDVR
LIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESERDEDGFLYMVYA
SQETFGTALAV, plus a hGH polyadenylation signal and additional polyadenylation signal). The RMCE vector was transfected into a
TaconicArtemis C57BL/6 ES cell line containing RMCE docking sites in the Rosa26 locus. Recombinant clones were isolated via
positive–negative (NeoR) selection. All mice in this study were maintained on a C57BL/6J background. Mice of both genders
were used in all experiments, aged between 8-9.5 months old. Animals were subjected to the following husbandry conditions:
mice were housed in temperature-controlled rooms at 21C, with 45-65% relative humidity and 12h/12h light/dark cycle. Mice
had ad libitum access to food and water, and were regularly subjected to health and welfare monitoring as standard (twice-daily).
All mice in this study had automatic watering (0.2 micron sterile filtered), and were fed rodent diet ‘‘R&M No.3, 9.5 mm pelleted (irra-
diated)’’ consisting of (proximate analysis) 10%moisture, 4.16%crude oil, 21.86%crude protein, 4.33%crude fiber, 7.89%Ash and
51.24% nitrogen-free extract; Special Diets Services, UK. All cages had corn-cob substrate (provided as a nest-pack) and sizzle-
nest material provided. Environmental enrichment was provided for all animals, with a cardboard tunnel for amalgamated females,
single-housed males and squabbling males. Cages were changed as needed, but all cages were changed on at least a two-weekly
cycle. Genotyping was performed by diagnostic end-point PCR using genomic DNA isolated from tissue biopsy specimens. WT and
KO alleles were detected using KOD Hot Start DNA polymerase (EMD Millipore) and manufacturer-recommended conditions. Gen-
otyping for mito-QC was performed as previously described (McWilliams et al., 2016). For mCherry-GFP-LC3 autophagy reporter
mice, genotyping was performed with the following primer sets, at an annealing temperature of 60C: PRIMER 7336_5: CAAAGACC
CCAACGAGAAGC; PRIMER 3579_152: hGH pA 30 1:CCAAGGCACACAAAAAACC; PRIMER 1114_1: CTCTTCCCTCGTGATCTGCA
ACTCC; PRIMER 1114_2: CATGTCTTTAATCTACCTCGATGG; with expected amplicons of 299 bp (WT) and 614 (LC3 Reporter). All
animal studies and breeding was approved by the University of Dundee ethical review committee, and further subjected to approved
study plans by the Named Veterinary Surgeon and ComplianceOfficer (Dr. Ngaire Dennison) and performed under a UKHomeOffice
project license in accordance with the Animal Scientific Procedures Act (ASPA, 1986).
In Vitro Models
For experiments using primary MEFs, embryos were derived from time-mated pregnant females at E12-E16.5 and staged according
to the criteria of (Theiler, 1989). PrimaryMEFs were generated frommito-QCPink1 embryos (sex unknown) using standard protocols,
maintained in DMEM/20% FBS/penicillin-streptomycin at 37C/5%CO2 as previously described (McWilliams et al., 2016). For some
experiments, we used immortalized MEFs (sex unknown, generated using standard procedures – stable transduction of SV40 Large
T Antigen) maintained as above.
METHOD DETAILS
Stimulation of Mitophagy
Stimulations with CCCP (20 mM), 3-NPA (20 mM) and DFP (1 mM) were performed as previously described (Allen et al., 2013). For
in vivo experiments, cohorts of adult mito-QC animals were administered I.P. injections of 3-NPA (Sigma Aldrich) for 24h and
7 days (50 mg/kg for 5 days, 75 mg/kg for two days), after which terminal anesthesia and trans-cardial perfusion were performed
to obtain tissues for histological analyses.
Histology, Immunochemistry & Confocal Microscopy
Immunocytochemistry, immunohistochemistry and microscopy were performed as previously described (McWilliams et al., 2016;
Allen et al., 2013), with minor modifications. Following terminal anesthesia via I.P. administration of Euthatal, adult animals were
trans-cardially perfused with PBS to remove excess blood. Tissues were rapidly harvested and processed by immersion fixation
in freshly prepared 3.7% PFA at pH 7.0 in 0.2M HEPES. Transverse brain sections (200 mm) were acquired using a vibratome (Leica).
For cryosectioning, tissues were cryoprotected in 30% (w/v) sucrose in PBS at 4C. Coronal brain sections (40 mm) were acquired
using sledge microtome equipped with a freezing stage (Leitz) and processed for free-floating immunohistochemistry. Non-neural
organs were embedded in OCT (Sakura) and sectioned using a cryostat (Leica). The following primary antibodies were used: rat
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anti-LAMP1 (Santa Cruz Biotechnology, Inc.); Rabbit, sheep and mouse anti-Tyrosine Hydroxylase (Millipore); Rabbit anti-Iba1
(Wako). Alexa-Fluor conjugated secondary antibodies were obtained from Life Technologies (Molecular Probes). Details of antibody
catalog numbers/RRIDs are available in the associated Key Resources Table that accompanies this paper. VECTASHIELD Antifade
Mounting Medium H-1000 was used to mount tissue sections on slides (Leica Surgipath). Images were acquired using a Zeiss
LSM 710 Laser Scanning Microscope (Plan-Neofuar 340 objective, NA 1.30; Plan Apochromat 363 objective NA 1.4; Plan
Apochromat 320 objective, NA 0.8), or a Zeiss LSM880 Airyscan Confocal Scanning microscope (ZEISS; Plan Apochromat 363
objective, NA 1.4) and processed using ZEISS Zen Software/Adobe Photoshop or Imaris (Bitplane) for 3D Isosurface Rendering.
Images were digitally altered within linear parameters, with minimal adjustments to levels and linear contrast applied to all images.
Tissue Harvesting and Preparation of Protein Lysates
Fresh brains were rapidly excised, placed in cold PBS andmicrodissected with ultrafine microknives under stereomicroscopy. Upon
isolation, each brain region was collected in a single 1.5 ml microcentrifuge tube and immediately plunged into dry ice. Mouse extra-
neural tissues (visceral tissues, skeletal muscle) were rapidly dissected, excised and rinsed briefly in ultra-chilled PBS to remove
excess blood and snap frozen in liquid N2. Tissue samples were stored at -80
C until ready for processing. To make protein extracts,
all tissues (neural subregions and extra-neural tissues) were weighed and defrosted on wet ice in 5-fold mass excess of freshly pre-
pared, ice-cold lysis buffer containing: 50 mM Tris/HCl, pH 7.5, 1 mM EDTA pH 8.0, 1 mM EGTA pH 8.0, 1% Triton X-100, 0.25 M
sucrose, 150 mM NaCl, 2 mM sodium orthovanadate, 1 mM NaF, 10 mM Sodium glycerolphosphate, 1.15 mM Sodium Molybdate,
4 mM Sodium tartrate dehydrate, 100 mM 2-Chloroacetamide, 1 mM DTT and Complete protease inhibitor cocktail (Roche). All
inhibitors and DTT were added immediately prior to use. Tissue homogenisation was performed using a probe sonicator at 4C
(Branson Instruments). Crude lysates were incubated at 4C on wet ice for 30-45 min, before clarification by centrifugation at
14,000 rpm for 30 min at 4C. Supernatants used for subsequent steps were carefully removed and either used for downstream
biochemical analyses or snap-frozen and stored at 80C.
Immunoblotting
Briefly, 20 mg of denatured protein lysates were resolved by SDS-PAGE using precast 4–12% Novex Bis-Acrylamide gels (Thermo
Fisher Scientific). Gels were electrotransfered to Immobilon-P PVDF membrane (Millipore) using a Bio-Rad Transblot Transfer
Apparatus. Equal loading was evaluated by briefly incubating membranes with the reversible protein-binding dye, Ponceau-S
(Sigma-Aldrich). Membranes were incubated with primary antibodies overnight at 4C in either 5% (wt/vol) nonfat dry milk (Marvel)
or 5% bovine serum albumin (BSA) diluted in TBST (Tris-buffered saline with 0.1% Tween-20). After washes in TBST, secondary
detection was performed with HRP-conjugated secondary antibodies (1:5,000). Membranes were washed in TBST and developed
using standard chemiluminescence with ECL (Amersham) and exposure to hyperfilm (GE Healthcare). MEF cells were processed for
biochemical analyses as previously described (Allen et al., 2013). To detect ubiquitylated CISD1 and phospho ubiquitin in adult
fibroblasts, ubiquitin capture was employed using recombinant TUBEs (His-Halo-UBAUBQLN1 #: DU23799, PPAD, MRC PPU) as
described in Ordureau et al. (2014).
Detection of Endogenous PINK1 Protein in Mouse Tissues
To enrich and detect endogenous mouse PINK1 protein, the total pool was first immunoprecipitated by incubating with sheep anti-
mouse PINK1 covalently-coupled to protein-G sepharose beads (1 mg per ml beads; #S774C, 3rd Bleed), from 0.3-5 mg of lysate. IPs
were performed overnight (18 hours) at 4Cwith constant agitation on awheel shaker set to approximately 25 rpm and protected from
light. Lysis buffer supplemented with inhibitors/DTT was used to wash beads. In total beads were subjected to two washes with NaCl
300 mM, and two with 150 mM NaCl. Protein was eluted in 2X LDS (NuPAGE), subjected to 95C for 3 min and eluted using a SpinX
column, after which reducing agent (beta-mercaptoethanol) was added. Samples were resolved by SDS-PAGE, as described above.
Detection of endogenous PINK1 was performed by immunoblotting, using sheep anti-mouse PINK1 #S086D (1-2 mg/ml, 3rd Bleed)
and developed using standard chemiluminescence. All antibodies to endogenous mouse PINK1 were generated by MRC PPU
Reagents and Services, University of Dundee (http://mrcppureagents.dundee.ac.uk/).
Detection of Endogenous Mouse PINK1 Protein in Brain Regions by Mass Spectrometry
Endogenousmouse PINK1was immunoprecipitated as described above from sub-dissected adult brain regions (cortex, cerebellum)
obtained from Pink1 WT and KO mice. Lysates were resolved by SDS-PAGE and gels were processed for in-gel trypsin digestion.
Briefly, bands were revealed using Colloidal Coomassie R-250 and a gel region corresponding to >50-75 kDa was excised under
aseptic, keratin-free conditions. Following de-staining steps and reduction using 5mM DTT (65C, 20 min with agitation) and alkyl-
ation by 20 mM chloroacetamide (RT, 20 min with agitation), samples were digested overnight at 30C in mass spectrometry grade
trypsin, in 50 mM Triethylamonium bicarbonate. Peptides were extracted with 100% acetonitrile (ACN), dried via Speed-Vac and
samples were then submitted to the MRC PPU Mass Spectrometry Facility for further analysis. Briefly, peptides were analysed by
liquid chromatography (LC)-MS/MS using a Thermo U3000 RSLC Nano Liquid Chromatography system (Thermo-Fisher Scientific)
coupled to a Thermo LTQ-Orbitrap Velos mass spectrometer (Thermo-Fisher Scientific). To avoid any potential contamination from
WT protein, Pink1 KO samples were run initially, followed by a blank and then WT preparations. Data files were searched using
Mascot (www.matrixscience.com). Extracted Ion chromatograms (XICs) were obtained from mass spectrometry RAW data files us-
ing Xcalibur v2.2 (Thermo-Fisher Scientific). The mass range used was the observed m/z value of the relevant peptides +/- 10 ppm.
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QUANTIFICATION AND STATISTICAL ANALYSIS
Semi-Automated Quantitation
Images were processed with Volocity 6.3 Image Analysis Software (PerkinElmer) using algorithms developed to analyze object over-
lap and count individual structures. For all analyses, we obtained images using uniform random sampling by an experimenter blind to
all conditions. All images in each experimental group were processed as a batch using identical protocols. All images were pre-
filtered to suppress noise (3x3 median filter). The same strategy was used to quantify all non-immunolabelled mito-QC-labelled im-
ages using auto-thresholding to identify objects (mean intensity +3 standard deviations). Objects were filtered using a minimum size
cutoff (0.16 mm2) and touching objects were separated using a guide size (0.4 mm2). Mitolysosomes were typically identified on the
basis of thresholded red signal not overlapping with green (this condition was relaxed in the case of samples affected by heat-medi-
ated dequenching of the mito-QC probe during tissue processing). Where dequenching or spectral-overlap was observed in some
instances, we employed LAMP1-immunohistochemistry to verify the lysosomal nature of mitolysosomes and green channel/
combined with LAMP1 immunostaining was used as a proxy for mitolysosomes. In the case of immunolabels used to identify cells
of interest in brain sections (TH, Iba1), we employed a autothresholding criterion of mean intensity +1.5 standard deviations. A min-
imum size of 0.16 mm2 was required, and a "Fill Holes in Objects" processing step was applied. Blood vessels were identified on the
basis of high green channel intensity and distinctive morphology. For fasting experiments, a fixed intensity threshold was established
by autothresholding (mean +3 standard deviations) images and acquisition of a mean value fromControl animals. This threshold was
applied to both control and fasted animal images.
Statistical Analysis
Data are depicted as scatter plots with each data point representing the mean value of an individual animal subject, ± standard
error of the mean (SEM). Numbers of subjects are indicated in the respective figure legends. Statistical analyses were performed
in GraphPad Prism and/or RStudio. Student’s t-test was used for pairwise comparisons, whereas multiple comparisons were
analyzed with one-way analysis of variance (ANOVA) and Bonferonni’s post hoc test where indicated in the figure legends. No
methods were used to determine whether the data met assumptions of the statistical approach.
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